Home › Funds › Casdin Capital › MXCT
Casdin Capital position in MXCT
MAXCYTE INC · Health Care
Latest position (Q3 2023)1.89M sh
Reported value held$5.90M
Portfolio Weight0.65%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 13.97M | $170.59M | New |
| Q4 2021 | 13.97M | $142.37M | Hold |
| Q1 2022 | 13.97M | $97.66M | Hold |
| Q2 2022 | 13.97M | $66.08M | Hold |
| Q3 2022 | 10.74M | $69.78M | Reduce |
| Q4 2022 | 9.51M | $51.90M | Reduce |
| Q1 2023 | 4.92M | $24.38M | Reduce |
| Q2 2023 | 4.71M | $21.64M | Reduce |
| Q3 2023 | 1.89M | $5.90M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026
- Point72 Asset Management 299.85K sh · $368.82K · Q2 2026